Home ➤ Life Science ➤ Therapeutics ➤ Non-Opioid Pain Treatment Market
Non-Opioid Pain Treatment Market
Published date: June 2025 • Formats:
Request Sample Schedule a Call

Non-Opioid Pain Treatment Market By Drug Class (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Acetaminophen, Local Anesthetics, Antidepressants, Anticonvulsants, Corticosteroids and Others), By Application (Neuropathic Pain, Chronic Pain, Post-operative Pain and Acute Pain), By Route of Administration (Oral, Topical, Injectable and Other Route of Administration), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

  • Published date: June 2025
  • Report ID: 151641
  • Number of Pages: 326
  • Format:
  • keyboard_arrow_up
    • 1. Executive Summary
      • 1.1. Definition
      • 1.2. Market Snapshot
      • 1.3. Market Overview
      • 1.4. Segment Overview
      • 1.5. Regional Overview
      • 1.6. Competitive Landscape
      • 1.7. Taxonomy
      • 1.8. Industry Voices
    • 2. Global Market Overview
      • 2.1. Global Market Insights and Industry Overview
      • 2.2. Market Dynamics
        • 2.2.1. Drivers
        • 2.2.2. Restraints
        • 2.2.3. Opportunities
        • 2.2.4. Key Non-Opioid Pain Treatment Market Trends
      • 2.3. Application Landscape
      • 2.4. Regulatory Framework
      • 2.5. Sustainability and ESG (Environmental, Social, Governance)
      • 2.6. Opportunity Map Analysis
      • 2.7. Opportunity Orbits
      • 2.8. PESTLE Analysis
      • 2.9. PORTER’S Five Force Analysis
      • 2.10. Drivers & Restraints Impact Analysis
      • 2.11. Value Chain Analysis
        • 2.11.1. List of Raw Materials Suppliers
        • 2.11.2. List of Non-Opioid Pain Treatment Manufacturers
        • 2.11.3. List of Dealer/Distributors
      • 2.12. Regional Market Share and BPS Analysis
      • 2.13. Impact of Macro-economic Factors/Geopolitical Factors
    • 3. Global Non-Opioid Pain Treatment Market Analysis and Forecast, By Segment, 2020-2034
      • 3.1. Key Findings
      • 3.2. Global Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2020-2034
      • 3.3. Global Non-Opioid Pain Treatment Market Attractiveness Analysis, By Drug Class
        • 3.3.1. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
          • 3.3.1.1. Insights
          • 3.3.1.2. Key Takeaways
        • 3.3.2. Acetaminophen
          • 3.3.2.1. Insights
          • 3.3.2.2. Key Takeaways
        • 3.3.3. Local Anesthetics
          • 3.3.3.1. Insights
          • 3.3.3.2. Key Takeaways
        • 3.3.4. Antidepressants
          • 3.3.4.1. Insights
          • 3.3.4.2. Key Takeaways
        • 3.3.5. Anticonvulsants
          • 3.3.5.1. Insights
          • 3.3.5.2. Key Takeaways
        • 3.3.6. Corticosteroids
          • 3.3.6.1. Insights
          • 3.3.6.2. Key Takeaways
        • 3.3.7. Others
          • 3.3.7.1. Insights
          • 3.3.7.2. Key Takeaways
      • 3.4. Global Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 3.5. Global Non-Opioid Pain Treatment Market Attractiveness Analysis, By Application
        • 3.5.1. Neuropathic Pain
          • 3.5.1.1. Insights
          • 3.5.1.2. Key Takeaways
        • 3.5.2. Chronic Pain
          • 3.5.2.1. Insights
          • 3.5.2.2. Key Takeaways
        • 3.5.3. Post-operative Pain
          • 3.5.3.1. Insights
          • 3.5.3.2. Key Takeaways
        • 3.5.4. Acute Pain
          • 3.5.4.1. Insights
          • 3.5.4.2. Key Takeaways
      • 3.6. Global Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2020-2034
      • 3.7. Global Non-Opioid Pain Treatment Market Attractiveness Analysis, By Route of Administration
        • 3.7.1. Oral
          • 3.7.1.1. Insights
          • 3.7.1.2. Key Takeaways
        • 3.7.2. Topical
          • 3.7.2.1. Insights
          • 3.7.2.2. Key Takeaways
        • 3.7.3. Injectable
          • 3.7.3.1. Insights
          • 3.7.3.2. Key Takeaways
        • 3.7.4. Other Route of Administration
          • 3.7.4.1. Insights
          • 3.7.4.2. Key Takeaways
      • 3.8. Global Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
      • 3.9. Global Non-Opioid Pain Treatment Market Attractiveness Analysis, By Distribution Channel
        • 3.9.1. Retail Pharmacies
          • 3.9.1.1. Insights
          • 3.9.1.2. Key Takeaways
        • 3.9.2. Hospital Pharmacies
          • 3.9.2.1. Insights
          • 3.9.2.2. Key Takeaways
        • 3.9.3. Online Pharmacies
          • 3.9.3.1. Insights
          • 3.9.3.2. Key Takeaways
    • 4. Global Non-Opioid Pain Treatment Market Analysis and Forecast, By Region, 2020-2034
      • 4.1. Key Findings
      • 4.2. Global Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2020-2034
        • 4.2.1. North America
          • 4.2.1.1. Regional Insights
        • 4.2.2. Europe
          • 4.2.2.1. Regional Insights
        • 4.2.3. Asia Pacific
          • 4.2.3.1. Regional Insights
        • 4.2.4. Latin America
          • 4.2.4.1. Regional Insights
        • 4.2.5. Middle East & Africa
          • 4.2.5.1. Regional Insights
      • 4.3. Global Non-Opioid Pain Treatment Market Attractiveness Analysis, By Region
    • 5. North America Non-Opioid Pain Treatment Market Analysis and Forecast, 2020-2034
      • 5.1. Key Findings
      • 5.2. North America Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2020-2034
      • 5.3. North America Non-Opioid Pain Treatment Market Attractiveness Analysis, By Drug Class
      • 5.4. North America Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 5.5. North America Non-Opioid Pain Treatment Market Attractiveness Analysis, By Application
      • 5.6. North America Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2020-2034
      • 5.7. North America Non-Opioid Pain Treatment Market Attractiveness Analysis, By Route of Administration
      • 5.8. North America Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
      • 5.9. North America Non-Opioid Pain Treatment Market Attractiveness Analysis, By Distribution Channel
      • 5.10. North America Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 5.11. North America Non-Opioid Pain Treatment Market Attractiveness Analysis, By Country
        • 5.11.1. The US
        • 5.11.2. Canada
    • 6. Europe Non-Opioid Pain Treatment Market Analysis and Forecast, 2020-2034
      • 6.1. Key Findings
      • 6.2. Europe Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2020-2034
      • 6.3. Europe Non-Opioid Pain Treatment Market Attractiveness Analysis, By Drug Class
      • 6.4. Europe Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 6.5. Europe Non-Opioid Pain Treatment Market Attractiveness Analysis, By Application
      • 6.6. Europe Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2020-2034
      • 6.7. Europe Non-Opioid Pain Treatment Market Attractiveness Analysis, By Route of Administration
      • 6.8. Europe Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
      • 6.9. Europe Non-Opioid Pain Treatment Market Attractiveness Analysis, By Distribution Channel
      • 6.10. Europe Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 6.11. Europe Non-Opioid Pain Treatment Market Attractiveness Analysis, By Country
        • 6.11.1. Germany
        • 6.11.2. The UK
        • 6.11.3. France
        • 6.11.4. Spain
        • 6.11.5. Italy
        • 6.11.6. Russia
        • 6.11.7. Netherland
        • 6.11.8. Rest of Europe
    • 7. Asia Pacific Non-Opioid Pain Treatment Market Analysis and Forecast, 2020-2034
      • 7.1. Key Findings
      • 7.2. Asia Pacific Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2020-2034
      • 7.3. Asia Pacific Non-Opioid Pain Treatment Market Attractiveness Analysis, By Drug Class
      • 7.4. Asia Pacific Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 7.5. Asia Pacific Non-Opioid Pain Treatment Market Attractiveness Analysis, By Application
      • 7.6. Asia Pacific Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2020-2034
      • 7.7. Asia Pacific Non-Opioid Pain Treatment Market Attractiveness Analysis, By Route of Administration
      • 7.8. Asia Pacific Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
      • 7.9. Asia Pacific Non-Opioid Pain Treatment Market Attractiveness Analysis, By Distribution Channel
      • 7.10. Asia Pacific Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 7.11. Asia Pacific Non-Opioid Pain Treatment Market Attractiveness Analysis, By Country
        • 7.11.1. China
        • 7.11.2. Japan
        • 7.11.3. South Korea
        • 7.11.4. India
        • 7.11.5. Australia
        • 7.11.6. New Zealand
        • 7.11.7. Singapore
        • 7.11.8. Thailand
        • 7.11.9. Vietnam
        • 7.11.10. Rest of Asia Pacific
    • 8. Latin America Non-Opioid Pain Treatment Market Analysis and Forecast, 2020-2034
      • 8.1. Key Findings
      • 8.2. Latin America Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2020-2034
      • 8.3. Latin America Non-Opioid Pain Treatment Market Attractiveness Analysis, By Drug Class
      • 8.4. Latin America Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 8.5. Latin America Non-Opioid Pain Treatment Market Attractiveness Analysis, By Application
      • 8.6. Latin America Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2020-2034
      • 8.7. Latin America Non-Opioid Pain Treatment Market Attractiveness Analysis, By Route of Administration
      • 8.8. Latin America Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
      • 8.9. Latin America Non-Opioid Pain Treatment Market Attractiveness Analysis, By Distribution Channel
      • 8.10. Latin America Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 8.11. Latin America Non-Opioid Pain Treatment Market Attractiveness Analysis, By Country
        • 8.11.1. Brazil
        • 8.11.2. Mexico
        • 8.11.3. Rest of Latin America
    • 9. Middle East & Africa Non-Opioid Pain Treatment Market Analysis and Forecast, 2020-2034
      • 9.1. Key Findings
      • 9.2. Middle East & Africa Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2020-2034
      • 9.3. Middle East & Africa Non-Opioid Pain Treatment Market Attractiveness Analysis, By Drug Class
      • 9.4. Middle East & Africa Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 9.5. Middle East & Africa Non-Opioid Pain Treatment Market Attractiveness Analysis, By Application
      • 9.6. Middle East & Africa Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2020-2034
      • 9.7. Middle East & Africa Non-Opioid Pain Treatment Market Attractiveness Analysis, By Route of Administration
      • 9.8. Middle East & Africa Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
      • 9.9. Middle East & Africa Non-Opioid Pain Treatment Market Attractiveness Analysis, By Distribution Channel
      • 9.10. Middle East & Africa Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 9.11. Middle East & Africa Non-Opioid Pain Treatment Market Attractiveness Analysis, By Country
        • 9.11.1. South Africa
        • 9.11.2. Saudi Arabia
        • 9.11.3. UAE
        • 9.11.4. Rest of Middle East & Africa
    • 10. Competitive Landscape & Company Profiles
      • 10.1. Market Competition Scenario Analysis, By Company
        • 10.1.1. Key Takeaways
      • 10.2. Overview of Major Market Players
      • 10.3. Competitor Landscape
      • 10.4. Strategic Mapping
      • 10.5. Company Life Cycle Analysis
      • 10.6. Company Market Share Analysis
      • 10.7. Company Profiles
        • 10.7.1. Novartis AG
          • 10.7.1.1. Company Details
          • 10.7.1.2. Business Overview
          • 10.7.1.3. Product Portfolio
          • 10.7.1.4. Financial Insights
          • 10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.1.6. SWOT Analysis
          • 10.7.1.7. Geographic Footprint
        • 10.7.2. Teva Pharmaceutical Industries Ltd.
          • 10.7.2.1. Company Details
          • 10.7.2.2. Business Overview
          • 10.7.2.3. Product Portfolio
          • 10.7.2.4. Financial Insights
          • 10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.2.6. SWOT Analysis
          • 10.7.2.7. Geographic Footprint
        • 10.7.3. Dr. Reddy’s Laboratories Ltd.
          • 10.7.3.1. Company Details
          • 10.7.3.2. Business Overview
          • 10.7.3.3. Product Portfolio
          • 10.7.3.4. Financial Insights
          • 10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.3.6. SWOT Analysis
          • 10.7.3.7. Geographic Footprint
        • 10.7.4. Sun Pharmaceutical Industries Ltd.
          • 10.7.4.1. Company Details
          • 10.7.4.2. Business Overview
          • 10.7.4.3. Product Portfolio
          • 10.7.4.4. Financial Insights
          • 10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.4.6. SWOT Analysis
          • 10.7.4.7. Geographic Footprint
        • 10.7.5. GSK plc
          • 10.7.5.1. Company Details
          • 10.7.5.2. Business Overview
          • 10.7.5.3. Product Portfolio
          • 10.7.5.4. Financial Insights
          • 10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.5.6. SWOT Analysis
          • 10.7.5.7. Geographic Footprint
        • 10.7.6. Pfizer Inc.
          • 10.7.6.1. Company Details
          • 10.7.6.2. Business Overview
          • 10.7.6.3. Product Portfolio
          • 10.7.6.4. Financial Insights
          • 10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.6.6. SWOT Analysis
          • 10.7.6.7. Geographic Footprint
        • 10.7.7. Perrigo Company plc
          • 10.7.7.1. Company Details
          • 10.7.7.2. Business Overview
          • 10.7.7.3. Product Portfolio
          • 10.7.7.4. Financial Insights
          • 10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.7.6. SWOT Analysis
          • 10.7.7.7. Geographic Footprint
        • 10.7.8. Cipla Ltd.
          • 10.7.8.1. Company Details
          • 10.7.8.2. Business Overview
          • 10.7.8.3. Product Portfolio
          • 10.7.8.4. Financial Insights
          • 10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.8.6. SWOT Analysis
          • 10.7.8.7. Geographic Footprint
        • 10.7.9. Johnson & Johnson Services, Inc.
          • 10.7.9.1. Company Details
          • 10.7.9.2. Business Overview
          • 10.7.9.3. Product Portfolio
          • 10.7.9.4. Financial Insights
          • 10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.9.6. SWOT Analysis
          • 10.7.9.7. Geographic Footprint
        • 10.7.10. Pacira Pharmaceuticals, Inc.
          • 10.7.10.1. Company Details
          • 10.7.10.2. Business Overview
          • 10.7.10.3. Product Portfolio
          • 10.7.10.4. Financial Insights
          • 10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.10.6. SWOT Analysis
          • 10.7.10.7. Geographic Footprint
        • 10.7.11. Pierrel S.p.A.
          • 10.7.11.1. Company Details
          • 10.7.11.2. Business Overview
          • 10.7.11.3. Product Portfolio
          • 10.7.11.4. Financial Insights
          • 10.7.11.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.11.6. SWOT Analysis
          • 10.7.11.7. Geographic Footprint
        • 10.7.12. Vertex Pharmaceuticals
          • 10.7.12.1. Company Details
          • 10.7.12.2. Business Overview
          • 10.7.12.3. Product Portfolio
          • 10.7.12.4. Financial Insights
          • 10.7.12.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.12.6. SWOT Analysis
          • 10.7.12.7. Geographic Footprint
        • 10.7.13. Assertio Therapeutics
          • 10.7.13.1. Company Details
          • 10.7.13.2. Business Overview
          • 10.7.13.3. Product Portfolio
          • 10.7.13.4. Financial Insights
          • 10.7.13.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.13.6. SWOT Analysis
          • 10.7.13.7. Geographic Footprint
        • 10.7.14. Mylan N.V. (Viatris)
          • 10.7.14.1. Company Details
          • 10.7.14.2. Business Overview
          • 10.7.14.3. Product Portfolio
          • 10.7.14.4. Financial Insights
          • 10.7.14.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.14.6. SWOT Analysis
          • 10.7.14.7. Geographic Footprint
        • 10.7.15. Flexion Therapeutics
          • 10.7.15.1. Company Details
          • 10.7.15.2. Business Overview
          • 10.7.15.3. Product Portfolio
          • 10.7.15.4. Financial Insights
          • 10.7.15.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.15.6. SWOT Analysis
          • 10.7.15.7. Geographic Footprint
    • 11. Methodology and Data Source
      • 11.1. Methodology/Research Approach
      • 11.2. Market Size Estimation
      • 11.3. Market Breakdown and Data Triangulation
      • 11.4. Data Source
      • 11.5. Secondary Sources
      • 11.6. Primary Sources
      • 11.7. Appendix
      • 11.8. Disclaimer
    • List of Tables
      • Table 1. Global Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 2. Global Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
      • Table 3. Global Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
      • Table 4. Global Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 5. Global Non-Opioid Pain Treatment Market Value (US$ Mn), By Region, 2020-2034
      • Table 6. North America Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 7. North America Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
      • Table 8. North America Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
      • Table 9. North America Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 10. North America Non-Opioid Pain Treatment Market Value (US$ Mn), By Country, 2020-2034
      • Table 11. The US Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 12. The US Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
      • Table 13. The US Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
      • Table 14. The US Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 15. Canada Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 16. Canada Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
      • Table 17. Canada Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
      • Table 18. Canada Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 19. Europe Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 20. Europe Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
      • Table 21. Europe Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
      • Table 22. Europe Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 23. Europe Non-Opioid Pain Treatment Market Value (US$ Mn), By Country, 2020-2034
      • Table 24. Germany Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 25. Germany Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
      • Table 26. Germany Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
      • Table 27. Germany Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 28. The UK Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 29. The UK Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
      • Table 30. The UK Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
      • Table 31. The UK Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 32. France Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 33. France Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
      • Table 34. France Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
      • Table 35. France Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 36. Spain Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 37. Spain Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
      • Table 38. Spain Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
      • Table 39. Spain Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 40. Italy Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 41. Italy Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
      • Table 42. Italy Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
      • Table 43. Italy Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 44. Russia Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 45. Russia Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
      • Table 46. Russia Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
      • Table 47. Russia Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 48. Netherland Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 49. Netherland Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
      • Table 50. Netherland Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
      • Table 51. Netherland Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 52. Rest of Europe Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 53. Rest of Europe Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
      • Table 54. Rest of Europe Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
      • Table 55. Rest of Europe Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 56. Asia Pacific Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 57. Asia Pacific Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
      • Table 58. Asia Pacific Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
      • Table 59. Asia Pacific Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 60. Asia Pacific Non-Opioid Pain Treatment Market Value (US$ Mn), By Country, 2020-2034
      • Table 61. China Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 62. China Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
      • Table 63. China Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
      • Table 64. China Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 65. India Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 66. India Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
      • Table 67. India Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
      • Table 68. India Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 69. Japan Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 70. Japan Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
      • Table 71. Japan Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
      • Table 72. Japan Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 73. South Korea Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 74. South Korea Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
      • Table 75. South Korea Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
      • Table 76. South Korea Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 77. Australia Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 78. Australia Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
      • Table 79. Australia Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
      • Table 80. Australia Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 81. New Zealand Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 82. New Zealand Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
      • Table 83. New Zealand Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
      • Table 84. New Zealand Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 85. Singapore Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 86. Singapore Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
      • Table 87. Singapore Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
      • Table 88. Singapore Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 89. Thailand Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 90. Thailand Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
      • Table 91. Thailand Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
      • Table 92. Thailand Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 93. Vietnam Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 94. Vietnam Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
      • Table 95. Vietnam Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
      • Table 96. Vietnam Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 97. Rest of Asia Pacific Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 98. Rest of Asia Pacific Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
      • Table 99. Rest of Asia Pacific Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
      • Table 100. Rest of Asia Pacific Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 101. Latin America Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 102. Latin America Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
      • Table 103. Latin America Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
      • Table 104. Latin America Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 105. Latin America Non-Opioid Pain Treatment Market Value (US$ Mn), By Country, 2020-2034
      • Table 106. Brazil Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 107. Brazil Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
      • Table 108. Brazil Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
      • Table 109. Brazil Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 110. Mexico Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 111. Mexico Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
      • Table 112. Mexico Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
      • Table 113. Mexico Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 114. Rest of Latin America Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 115. Rest of Latin America Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
      • Table 116. Rest of Latin America Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
      • Table 117. Rest of Latin America Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 118. Middle East & Africa Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 119. Middle East & Africa Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
      • Table 120. Middle East & Africa Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
      • Table 121. Middle East & Africa Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 122. Middle East & Africa Non-Opioid Pain Treatment Market Value (US$ Mn), By Country, 2020-2034
      • Table 123. South Africa Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 124. South Africa Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
      • Table 125. South Africa Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
      • Table 126. South Africa Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 127. Saudi Arabia Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 128. Saudi Arabia Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
      • Table 129. Saudi Arabia Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
      • Table 130. Saudi Arabia Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 131. UAE Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 132. UAE Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
      • Table 133. UAE Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
      • Table 134. UAE Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 135. Rest of Middle East & Africa Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 136. Rest of Middle East & Africa Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
      • Table 137. Rest of Middle East & Africa Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
      • Table 138. Rest of Middle East & Africa Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
    • List of Figures
      • Figure 1. Global Non-Opioid Pain Treatment Market Snapshot: Market Value (US$ Mn), 2020-2034
      • Figure 2. Opportunity Map
      • Figure 3. Opportunity Orbit
      • Figure 4. Regional Market Share and BPS Analysis in Non-Opioid Pain Treatment Market
      • Figure 5. Global Non-Opioid Pain Treatment Market Analysis, By Drug Class, 2020, 2024 and 2034
      • Figure 6. Global Non-Opioid Pain Treatment Market Attractiveness Analysis, By Drug Class
      • Figure 7. Global Non-Opioid Pain Treatment Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 8. Global Non-Opioid Pain Treatment Market Attractiveness Analysis, By Application
      • Figure 9. Global Non-Opioid Pain Treatment Market Analysis, By Route of Administration, 2020, 2024 and 2034
      • Figure 10. Global Non-Opioid Pain Treatment Market Attractiveness Analysis, By Route of Administration
      • Figure 11. Global Non-Opioid Pain Treatment Market Analysis, By Distribution Channel, 2020, 2024 and 2034
      • Figure 12. Global Non-Opioid Pain Treatment Market Attractiveness Analysis, By Distribution Channel
      • Figure 13. Global Non-Opioid Pain Treatment Market Analysis, By Region, 2020, 2024 and 2034
      • Figure 14. Global Non-Opioid Pain Treatment Market Attractiveness Analysis, By Region
      • Figure 15. North America Non-Opioid Pain Treatment Market Analysis, By Drug Class, 2020, 2024 and 2034
      • Figure 16. North America Non-Opioid Pain Treatment Market Attractiveness Analysis, By Drug Class
      • Figure 17. North America Non-Opioid Pain Treatment Market (US$ Mn), by Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), 2020-2034
      • Figure 18. North America Non-Opioid Pain Treatment Market (US$ Mn), by Acetaminophen, 2020-2034
      • Figure 19. North America Non-Opioid Pain Treatment Market (US$ Mn), by Local Anesthetics, 2020-2034
      • Figure 20. North America Non-Opioid Pain Treatment Market (US$ Mn), by Antidepressants, 2020-2034
      • Figure 21. North America Non-Opioid Pain Treatment Market (US$ Mn), by Anticonvulsants, 2020-2034
      • Figure 22. North America Non-Opioid Pain Treatment Market (US$ Mn), by Corticosteroids, 2020-2034
      • Figure 23. North America Non-Opioid Pain Treatment Market (US$ Mn), by Others, 2020-2034
      • Figure 24. North America Non-Opioid Pain Treatment Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 25. North America Non-Opioid Pain Treatment Market Attractiveness Analysis, By Application
      • Figure 26. North America Non-Opioid Pain Treatment Market (US$ Mn), by Neuropathic Pain, 2020-2034
      • Figure 27. North America Non-Opioid Pain Treatment Market (US$ Mn), by Chronic Pain, 2020-2034
      • Figure 28. North America Non-Opioid Pain Treatment Market (US$ Mn), by Post-operative Pain, 2020-2034
      • Figure 29. North America Non-Opioid Pain Treatment Market (US$ Mn), by Acute Pain, 2020-2034
      • Figure 30. North America Non-Opioid Pain Treatment Market Analysis, By Route of Administration, 2020, 2024 and 2034
      • Figure 31. North America Non-Opioid Pain Treatment Market Attractiveness Analysis, By Route of Administration
      • Figure 32. North America Non-Opioid Pain Treatment Market (US$ Mn), by Oral, 2020-2034
      • Figure 33. North America Non-Opioid Pain Treatment Market (US$ Mn), by Topical, 2020-2034
      • Figure 34. North America Non-Opioid Pain Treatment Market (US$ Mn), by Injectable, 2020-2034
      • Figure 35. North America Non-Opioid Pain Treatment Market (US$ Mn), by Other Route of Administration, 2020-2034
      • Figure 36. North America Non-Opioid Pain Treatment Market Analysis, By Distribution Channel, 2020, 2024 and 2034
      • Figure 37. North America Non-Opioid Pain Treatment Market Attractiveness Analysis, By Distribution Channel
      • Figure 38. North America Non-Opioid Pain Treatment Market (US$ Mn), by Retail Pharmacies, 2020-2034
      • Figure 39. North America Non-Opioid Pain Treatment Market (US$ Mn), by Hospital Pharmacies, 2020-2034
      • Figure 40. North America Non-Opioid Pain Treatment Market (US$ Mn), by Online Pharmacies, 2020-2034
      • Figure 41. North America Non-Opioid Pain Treatment Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 42. North America Non-Opioid Pain Treatment Market Attractiveness Analysis, By Country
      • Figure 43. Europe Non-Opioid Pain Treatment Market Analysis, By Drug Class, 2020, 2024 and 2034
      • Figure 44. Europe Non-Opioid Pain Treatment Market Attractiveness Analysis, By Drug Class
      • Figure 45. Europe Non-Opioid Pain Treatment Market (US$ Mn), by Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), 2020-2034
      • Figure 46. Europe Non-Opioid Pain Treatment Market (US$ Mn), by Acetaminophen, 2020-2034
      • Figure 47. Europe Non-Opioid Pain Treatment Market (US$ Mn), by Local Anesthetics, 2020-2034
      • Figure 48. Europe Non-Opioid Pain Treatment Market (US$ Mn), by Antidepressants, 2020-2034
      • Figure 49. Europe Non-Opioid Pain Treatment Market (US$ Mn), by Anticonvulsants, 2020-2034
      • Figure 50. Europe Non-Opioid Pain Treatment Market (US$ Mn), by Corticosteroids, 2020-2034
      • Figure 51. Europe Non-Opioid Pain Treatment Market (US$ Mn), by Others, 2020-2034
      • Figure 52. Europe Non-Opioid Pain Treatment Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 53. Europe Non-Opioid Pain Treatment Market Attractiveness Analysis, By Application
      • Figure 54. Europe Non-Opioid Pain Treatment Market (US$ Mn), by Neuropathic Pain, 2020-2034
      • Figure 55. Europe Non-Opioid Pain Treatment Market (US$ Mn), by Chronic Pain, 2020-2034
      • Figure 56. Europe Non-Opioid Pain Treatment Market (US$ Mn), by Post-operative Pain, 2020-2034
      • Figure 57. Europe Non-Opioid Pain Treatment Market (US$ Mn), by Acute Pain, 2020-2034
      • Figure 58. Europe Non-Opioid Pain Treatment Market Analysis, By Route of Administration, 2020, 2024 and 2034
      • Figure 59. Europe Non-Opioid Pain Treatment Market Attractiveness Analysis, By Route of Administration
      • Figure 60. Europe Non-Opioid Pain Treatment Market (US$ Mn), by Oral, 2020-2034
      • Figure 61. Europe Non-Opioid Pain Treatment Market (US$ Mn), by Topical, 2020-2034
      • Figure 62. Europe Non-Opioid Pain Treatment Market (US$ Mn), by Injectable, 2020-2034
      • Figure 63. Europe Non-Opioid Pain Treatment Market (US$ Mn), by Other Route of Administration, 2020-2034
      • Figure 64. Europe Non-Opioid Pain Treatment Market Analysis, By Distribution Channel, 2020, 2024 and 2034
      • Figure 65. Europe Non-Opioid Pain Treatment Market Attractiveness Analysis, By Distribution Channel
      • Figure 66. Europe Non-Opioid Pain Treatment Market (US$ Mn), by Retail Pharmacies, 2020-2034
      • Figure 67. Europe Non-Opioid Pain Treatment Market (US$ Mn), by Hospital Pharmacies, 2020-2034
      • Figure 68. Europe Non-Opioid Pain Treatment Market (US$ Mn), by Online Pharmacies, 2020-2034
      • Figure 69. Europe Non-Opioid Pain Treatment Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 70. Europe Non-Opioid Pain Treatment Market Attractiveness Analysis, By Country
      • Figure 71. Asia Pacific Non-Opioid Pain Treatment Market Analysis, By Drug Class, 2020, 2024 and 2034
      • Figure 72. Asia Pacific Non-Opioid Pain Treatment Market Attractiveness Analysis, By Drug Class
      • Figure 73. Asia Pacific Non-Opioid Pain Treatment Market (US$ Mn), by Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), 2020-2034
      • Figure 74. Asia Pacific Non-Opioid Pain Treatment Market (US$ Mn), by Acetaminophen, 2020-2034
      • Figure 75. Asia Pacific Non-Opioid Pain Treatment Market (US$ Mn), by Local Anesthetics, 2020-2034
      • Figure 76. Asia Pacific Non-Opioid Pain Treatment Market (US$ Mn), by Antidepressants, 2020-2034
      • Figure 77. Asia Pacific Non-Opioid Pain Treatment Market (US$ Mn), by Anticonvulsants, 2020-2034
      • Figure 78. Asia Pacific Non-Opioid Pain Treatment Market (US$ Mn), by Corticosteroids, 2020-2034
      • Figure 79. Asia Pacific Non-Opioid Pain Treatment Market (US$ Mn), by Others, 2020-2034
      • Figure 80. Asia Pacific Non-Opioid Pain Treatment Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 81. Asia Pacific Non-Opioid Pain Treatment Market Attractiveness Analysis, By Application
      • Figure 82. Asia Pacific Non-Opioid Pain Treatment Market (US$ Mn), by Neuropathic Pain, 2020-2034
      • Figure 83. Asia Pacific Non-Opioid Pain Treatment Market (US$ Mn), by Chronic Pain, 2020-2034
      • Figure 84. Asia Pacific Non-Opioid Pain Treatment Market (US$ Mn), by Post-operative Pain, 2020-2034
      • Figure 85. Asia Pacific Non-Opioid Pain Treatment Market (US$ Mn), by Acute Pain, 2020-2034
      • Figure 86. Asia Pacific Non-Opioid Pain Treatment Market Analysis, By Route of Administration, 2020, 2024 and 2034
      • Figure 87. Asia Pacific Non-Opioid Pain Treatment Market Attractiveness Analysis, By Route of Administration
      • Figure 88. Asia Pacific Non-Opioid Pain Treatment Market (US$ Mn), by Oral, 2020-2034
      • Figure 89. Asia Pacific Non-Opioid Pain Treatment Market (US$ Mn), by Topical, 2020-2034
      • Figure 90. Asia Pacific Non-Opioid Pain Treatment Market (US$ Mn), by Injectable, 2020-2034
      • Figure 91. Asia Pacific Non-Opioid Pain Treatment Market (US$ Mn), by Other Route of Administration, 2020-2034
      • Figure 92. Asia Pacific Non-Opioid Pain Treatment Market Analysis, By Distribution Channel, 2020, 2024 and 2034
      • Figure 93. Asia Pacific Non-Opioid Pain Treatment Market Attractiveness Analysis, By Distribution Channel
      • Figure 94. Asia Pacific Non-Opioid Pain Treatment Market (US$ Mn), by Retail Pharmacies, 2020-2034
      • Figure 95. Asia Pacific Non-Opioid Pain Treatment Market (US$ Mn), by Hospital Pharmacies, 2020-2034
      • Figure 96. Asia Pacific Non-Opioid Pain Treatment Market (US$ Mn), by Online Pharmacies, 2020-2034
      • Figure 97. Asia Pacific Non-Opioid Pain Treatment Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 98. Asia Pacific Non-Opioid Pain Treatment Market Attractiveness Analysis, By Country
      • Figure 99. Latin America Non-Opioid Pain Treatment Market Analysis, By Drug Class, 2020, 2024 and 2034
      • Figure 100. Latin America Non-Opioid Pain Treatment Market Attractiveness Analysis, By Drug Class
      • Figure 101. Latin America Non-Opioid Pain Treatment Market (US$ Mn), by Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), 2020-2034
      • Figure 102. Latin America Non-Opioid Pain Treatment Market (US$ Mn), by Acetaminophen, 2020-2034
      • Figure 103. Latin America Non-Opioid Pain Treatment Market (US$ Mn), by Local Anesthetics, 2020-2034
      • Figure 104. Latin America Non-Opioid Pain Treatment Market (US$ Mn), by Antidepressants, 2020-2034
      • Figure 105. Latin America Non-Opioid Pain Treatment Market (US$ Mn), by Anticonvulsants, 2020-2034
      • Figure 106. Latin America Non-Opioid Pain Treatment Market (US$ Mn), by Corticosteroids, 2020-2034
      • Figure 107. Latin America Non-Opioid Pain Treatment Market (US$ Mn), by Others, 2020-2034
      • Figure 108. Latin America Non-Opioid Pain Treatment Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 109. Latin America Non-Opioid Pain Treatment Market Attractiveness Analysis, By Application
      • Figure 110. Latin America Non-Opioid Pain Treatment Market (US$ Mn), by Neuropathic Pain, 2020-2034
      • Figure 111. Latin America Non-Opioid Pain Treatment Market (US$ Mn), by Chronic Pain, 2020-2034
      • Figure 112. Latin America Non-Opioid Pain Treatment Market (US$ Mn), by Post-operative Pain, 2020-2034
      • Figure 113. Latin America Non-Opioid Pain Treatment Market (US$ Mn), by Acute Pain, 2020-2034
      • Figure 114. Latin America Non-Opioid Pain Treatment Market Analysis, By Route of Administration, 2020, 2024 and 2034
      • Figure 115. Latin America Non-Opioid Pain Treatment Market Attractiveness Analysis, By Route of Administration
      • Figure 116. Latin America Non-Opioid Pain Treatment Market (US$ Mn), by Oral, 2020-2034
      • Figure 117. Latin America Non-Opioid Pain Treatment Market (US$ Mn), by Topical, 2020-2034
      • Figure 118. Latin America Non-Opioid Pain Treatment Market (US$ Mn), by Injectable, 2020-2034
      • Figure 119. Latin America Non-Opioid Pain Treatment Market (US$ Mn), by Other Route of Administration, 2020-2034
      • Figure 120. Latin America Non-Opioid Pain Treatment Market Analysis, By Distribution Channel, 2020, 2024 and 2034
      • Figure 121. Latin America Non-Opioid Pain Treatment Market Attractiveness Analysis, By Distribution Channel
      • Figure 122. Latin America Non-Opioid Pain Treatment Market (US$ Mn), by Retail Pharmacies, 2020-2034
      • Figure 123. Latin America Non-Opioid Pain Treatment Market (US$ Mn), by Hospital Pharmacies, 2020-2034
      • Figure 124. Latin America Non-Opioid Pain Treatment Market (US$ Mn), by Online Pharmacies, 2020-2034
      • Figure 125. Latin America Non-Opioid Pain Treatment Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 126. Latin America Non-Opioid Pain Treatment Market Attractiveness Analysis, By Country
      • Figure 127. Middle East & Africa Non-Opioid Pain Treatment Market Analysis, By Drug Class, 2020, 2024 and 2034
      • Figure 128. Middle East & Africa Non-Opioid Pain Treatment Market Attractiveness Analysis, By Drug Class
      • Figure 129. Middle East & Africa Non-Opioid Pain Treatment Market (US$ Mn), by Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), 2020-2034
      • Figure 130. Middle East & Africa Non-Opioid Pain Treatment Market (US$ Mn), by Acetaminophen, 2020-2034
      • Figure 131. Middle East & Africa Non-Opioid Pain Treatment Market (US$ Mn), by Local Anesthetics, 2020-2034
      • Figure 132. Middle East & Africa Non-Opioid Pain Treatment Market (US$ Mn), by Antidepressants, 2020-2034
      • Figure 133. Middle East & Africa Non-Opioid Pain Treatment Market (US$ Mn), by Anticonvulsants, 2020-2034
      • Figure 134. Middle East & Africa Non-Opioid Pain Treatment Market (US$ Mn), by Corticosteroids, 2020-2034
      • Figure 135. Middle East & Africa Non-Opioid Pain Treatment Market (US$ Mn), by Others, 2020-2034
      • Figure 136. Middle East & Africa Non-Opioid Pain Treatment Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 137. Middle East & Africa Non-Opioid Pain Treatment Market Attractiveness Analysis, By Application
      • Figure 138. Middle East & Africa Non-Opioid Pain Treatment Market (US$ Mn), by Neuropathic Pain, 2020-2034
      • Figure 139. Middle East & Africa Non-Opioid Pain Treatment Market (US$ Mn), by Chronic Pain, 2020-2034
      • Figure 140. Middle East & Africa Non-Opioid Pain Treatment Market (US$ Mn), by Post-operative Pain, 2020-2034
      • Figure 141. Middle East & Africa Non-Opioid Pain Treatment Market (US$ Mn), by Acute Pain, 2020-2034
      • Figure 142. Middle East & Africa Non-Opioid Pain Treatment Market Analysis, By Route of Administration, 2020, 2024 and 2034
      • Figure 143. Middle East & Africa Non-Opioid Pain Treatment Market Attractiveness Analysis, By Route of Administration
      • Figure 144. Middle East & Africa Non-Opioid Pain Treatment Market (US$ Mn), by Oral, 2020-2034
      • Figure 145. Middle East & Africa Non-Opioid Pain Treatment Market (US$ Mn), by Topical, 2020-2034
      • Figure 146. Middle East & Africa Non-Opioid Pain Treatment Market (US$ Mn), by Injectable, 2020-2034
      • Figure 147. Middle East & Africa Non-Opioid Pain Treatment Market (US$ Mn), by Other Route of Administration, 2020-2034
      • Figure 148. Middle East & Africa Non-Opioid Pain Treatment Market Analysis, By Distribution Channel, 2020, 2024 and 2034
      • Figure 149. Middle East & Africa Non-Opioid Pain Treatment Market Attractiveness Analysis, By Distribution Channel
      • Figure 150. Middle East & Africa Non-Opioid Pain Treatment Market (US$ Mn), by Retail Pharmacies, 2020-2034
      • Figure 151. Middle East & Africa Non-Opioid Pain Treatment Market (US$ Mn), by Hospital Pharmacies, 2020-2034
      • Figure 152. Middle East & Africa Non-Opioid Pain Treatment Market (US$ Mn), by Online Pharmacies, 2020-2034
      • Figure 153. Middle East & Africa Non-Opioid Pain Treatment Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 154. Middle East & Africa Non-Opioid Pain Treatment Market Attractiveness Analysis, By Country
  • settingsSettings

Related Reports

Our Clients

  • Our Clients
Inquiry Before Buying

Non-Opioid Pain Treatment Market
  • 151641
  • June 2025
    • ★★★★★
      ★★★★★
    • (142)
add_shopping_cart Buy Now
Trusted by more than 17382 organizations globally
  • Client Logo
  • Client Logo
  • Client Logo
✖
Request a Sample Report
We'll get back to you as quickly as possible

Single User
$6,000
$3,999
USD / per unit
save 24%
Multi User
$8,000
$5,999
USD / per unit
save 28%
Corporate User
$10,000
$6,999
USD / per unit
save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization No up to 10 hrs work up to 30 hrs work
Accessibility 1 User 2-5 User Unlimited
Analyst Support up to 20 hrs up to 40 hrs up to 50 hrs
Benefit Up to 20% off on next purchase Up to 25% off on next purchase Up to 30% off on next purchase
Buy Now ($ 3,999) Buy Now ($ 5,999) Buy Now ($ 6,999)
Find Help
Legal
Explore
Secured Payment Options
Secured Payment Options